Skip to main content
. 2021 Apr 30;11:664927. doi: 10.3389/fonc.2021.664927

Figure 3.

Figure 3

Loss of RIPK3 activates STAT3 signals in Apcmin/+ mice. (A) The expression of pSTAT3 in 6-week-old Apcmin/+ and Apcmin/+Ripk3-/- intestinal tumors. (B) The levels of pSTAT3 in Apcmin/+ and Apcmin/+Ripk3-/- colonic crypts. (C) Quantitative mRNA expression of IL-6 in Apcmin/+ and Apcmin/+Ripk3-/- intestinal tumors. (D) The protein levels of IL-6 in Apcmin/+ and Apcmin/+Ripk3-/- intestinal tumors as determined by ELISA. (E) The expression of STAT3 target genes in Apcmin/+ and Apcmin/+Ripk3-/- intestinal tumors. (F) The expression of STAT3 target genes in Apcmin/+ and Apcmin/+Ripk3-/- colonic crypts. (G, H) Quantitative mRNA expression of STAT3 target genes in Apcmin/+ and Apcmin/+Ripk3-/- intestinal tumors and colonic crypts. *p < 0.05, **p < 0.01, ***p < 0.001 versus Apcmin/+ mice.